Kerecis has developed the unique, patented Kerecis™ Omega3 fish-skin acellular dermal matrix transplantation technology, where complete acellular fish skin is used for tissue regeneration by transplantation. The Kerecis™ Omega3 transplantation technology is used to reconstruct the skin in chronic wounds, for hernia repair, breast reconstruction and for dura restoration. Other tissue-transplant products are based on tissues of human and porcine origin. The Kerecis™ Omega3 fish skin offers improved economics and clinical performance, as well as reduced disease transfer risk and no cultural constraints on usage. Kerecis extracts proprietary mOmega3™ fatty acids from fish skin and incorporates in patented dermatological skin treatment products that are indicated to treat the symptoms of various skin inflammation diseases.